No effects on morphological growth have been observed in embryo-fetal advancement research with oral administration of methylphenidate to Expecting rats and rabbits through organogenesis at doses up to ten and 15 times, respectively, the most encouraged human dose (MRHD) of sixty mg/day given to ado